These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 8562975)
1. Megestrol acetate in neoplastic anorexia/cachexia: clinical evaluation and comparison with cytokine levels in patients with head and neck carcinoma treated with neoadjuvant chemotherapy. Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Santona MC; Del Giacco GS Int J Clin Lab Res; 1995; 25(3):135-41. PubMed ID: 8562975 [TBL] [Abstract][Full Text] [Related]
2. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer. Gebbia V; Testa A; Gebbia N Br J Cancer; 1996 Jun; 73(12):1576-80. PubMed ID: 8664133 [TBL] [Abstract][Full Text] [Related]
3. Results of a dose-intense phase 1 study of a combination chemotherapy regimen with cisplatin and epidoxorubicin including medroxyprogesterone acetate and recombinant interleukin-2 in patients with inoperable primary lung cancer. Mantovani G; Macciò A; Lai P; Massa E; Massa D; Mulas C; Succu G; Mudu MC; Manca G; Versace R; Pisano A J Immunother; 2000; 23(2):267-74. PubMed ID: 10746553 [TBL] [Abstract][Full Text] [Related]
4. Randomized trials of megestrol acetate for AIDS-associated anorexia and cachexia. Von Roenn JH Oncology; 1994 Oct; 51 Suppl 1():19-24. PubMed ID: 7970504 [TBL] [Abstract][Full Text] [Related]
5. Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms. Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC Crit Rev Oncog; 1998; 9(2):99-106. PubMed ID: 9973244 [TBL] [Abstract][Full Text] [Related]
6. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. Loprinzi CL; Ellison NM; Schaid DJ; Krook JE; Athmann LM; Dose AM; Mailliard JA; Johnson PS; Ebbert LP; Geeraerts LH J Natl Cancer Inst; 1990 Jul; 82(13):1127-32. PubMed ID: 2193166 [TBL] [Abstract][Full Text] [Related]
7. Megestrol acetate for treatment of anorexia and cachexia associated with human immunodeficiency virus infection. Von Roenn JH; Murphy RL; Wegener N Semin Oncol; 1990 Dec; 17(6 Suppl 9):13-6. PubMed ID: 2259923 [TBL] [Abstract][Full Text] [Related]
8. [Value of megestrol acetate in treatment of cachexia in head-neck tumors]. Büntzel J; Küttner K Laryngorhinootologie; 1995 Aug; 74(8):504-7. PubMed ID: 7575903 [TBL] [Abstract][Full Text] [Related]
9. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. Loprinzi CL; Michalak JC; Schaid DJ; Mailliard JA; Athmann LM; Goldberg RM; Tschetter LK; Hatfield AK; Morton RF J Clin Oncol; 1993 Apr; 11(4):762-7. PubMed ID: 8478668 [TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; Krook JE; Wilwerding MB; Rowland KM; Camoriano JK; Novotny PJ; Christensen BJ J Clin Oncol; 1999 Oct; 17(10):3299-306. PubMed ID: 10506633 [TBL] [Abstract][Full Text] [Related]
12. Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. Loprinzi CL; Bernath AM; Schaid DJ; Malliard JA; Athmann LM; Michalak JC; Tschetter LK; Hatfield AK; Morton RF Oncology; 1994 Oct; 51 Suppl 1():2-7. PubMed ID: 7970505 [TBL] [Abstract][Full Text] [Related]
13. The Bristol-Myers Anorexia/Cachexia Recovery Instrument (BACRI): a brief assessment of patients' subjective response to treatment for anorexia/cachexia. Cella DF; VonRoenn J; Lloyd S; Browder HP Qual Life Res; 1995 Jun; 4(3):221-31. PubMed ID: 7613532 [TBL] [Abstract][Full Text] [Related]
14. Megestrol acetate for anorexia and cachexia. Loprinzi CL; Johnson PA; Jensen M Oncology; 1992; 49 Suppl 2():46-9. PubMed ID: 1461628 [TBL] [Abstract][Full Text] [Related]
15. Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia. Vadell C; Seguí MA; Giménez-Arnau JM; Morales S; Cirera L; Bestit I; Batiste E; Blanco R; Jolis L; Boleda M; Antón I Am J Clin Oncol; 1998 Aug; 21(4):347-51. PubMed ID: 9708631 [TBL] [Abstract][Full Text] [Related]
16. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate. Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC Semin Oncol; 1998 Apr; 25(2 Suppl 6):45-52. PubMed ID: 9625383 [TBL] [Abstract][Full Text] [Related]
17. Low dose megestrol acetate can abrogate cachexia in advanced tumor patients receiving systemic interferon-alpha and/or interleukin-2 based antineoplastic therapy. Ackermann M; Kirchner H; Atzpodien J Anticancer Drugs; 1993 Oct; 4(5):585-7. PubMed ID: 8292817 [TBL] [Abstract][Full Text] [Related]
18. Appetite stimulation and weight gain with megestrol acetate. Aisner J; Parnes H; Tait N; Hickman M; Forrest A; Greco FA; Tchekmedyian NS Semin Oncol; 1990 Dec; 17(6 Suppl 9):2-7. PubMed ID: 2259925 [TBL] [Abstract][Full Text] [Related]
19. Usefulness of megestrol acetate in cancer cachexia and anorexia. A placebo-controlled study. Feliu J; González-Barón M; Berrocal A; Artal A; Ordóñez A; Garrido P; Zamora P; García de Paredes ML; Montero JM Am J Clin Oncol; 1992 Oct; 15(5):436-40. PubMed ID: 1524045 [TBL] [Abstract][Full Text] [Related]